MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.
One injection of nirsevimab reliably protects newborns against the development of RSV-associated lower respiratory tract infections.
Efficacy of antivirals and monoclonal antibodies for outpatient treatment of COVID-19 infection with the Omicron variant of SARS-CoV-2 coronavirus.
Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.
Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.